Publication | Open Access

Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial

UrologySurgical OncologyGastrointestinal OncologyMedicineBiliary CancerCancer TreatmentOncologyRadiation Oncology